Novel photocatalyst strategy enables light-gated polymerization targeting reactive oxygen species, suggesting new therapeutic applications.
Achieving spatiotemporal control over intracellular polymerization presents a fundamental challenge in merging synthetic chemistry with living systems. Here, we introduce a stimuli-responsive photocatalyst strategy that enables biomarker- and light-gated radical polymerization within cells. Engineered 3,4,5,6-tetrabromofluorescein (TBF) photocatalysts incorporate protecting groups─responsive to endogenous reactive oxygen/sulfur species (ROS/RSS) or enzymes─that suppress photoinduced electron/energy transfer-reversible addition-fragmentation chain transfer (PET-RAFT) activity until simultaneous biomarker activation and irradiation occur. This AND-gated mechanism confines polymerization exclusively to target cells. Leveraging monomer design and this dual-control paradigm, in situ polymer growth selectively disrupts endoplasmic reticulum (ER) integrity, triggering ER stress, calcium release, and paraptosis─a caspase-independent cell death pathway characterized by cytoplasmic vacuolization and ER dilation. This platform establishes a versatile chemical approach for precision organelle intervention, advancing therapeutic discovery and synthetic biology applications.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: